Literature DB >> 33584144

Study on the correlation between urinary retinol-binding protein and nonalcoholic fatty liver disease.

Chuang Li1, Weiwei Kong1, Lixia Kang1, Tiehan Zhang1, Weiqun Zhang1, Weidong Wang1.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) affects human health worldwide. Our objective was to explore the correlation between urinary retinol-binding protein (URBP) and NAFLD.
METHODS: This cross-sectional study included 445 NAFLD patients and 911 healthy controls. The URBP level and other parameters were measured.
RESULTS: The URBP level (expressed by the RBP/creatinine ratio) was higher in the NAFLD patients compared with the non-NAFLD patients. The urinary RBP/creatinine ratio was an independent risk factor for NAFLD after univariate and multivariate regression analysis, with the or values of 2.271 (1.795-2.872, P < 0.001) and 2.338 (1.775-3.080, P < 0.001), respectively. The prevalence of the urinary RBP/creatinine ratio (groups 1, 2, 3, 4) was 20.0%, 17.3%, 27.3%, and 35.4%, respectively (P < 0.001), and the prevalence of NAFLD in the high urinary RBP/creatinine ratio group was significantly higher than that in the low urinary RBP/creatinine ratio group.
CONCLUSIONS: Our results revealed that the urinary RBP/creatinine ratio was an independent risk factor for NAFLD. 2021 Chuang Li, Weiwei Kong, Lixia Kang, Tiehan Zhang, Weiqun Zhang, Weidong Wang, published by CEON/CEES.

Entities:  

Keywords:  nonalcoholic fatty liver disease; renal injury; retinol-binding protein

Year:  2021        PMID: 33584144      PMCID: PMC7857848          DOI: 10.5937/jomb0-24666

Source DB:  PubMed          Journal:  J Med Biochem        ISSN: 1452-8266            Impact factor:   3.402


  29 in total

1.  Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.

Authors:  G Marchesini; S Avagnina; E G Barantani; A M Ciccarone; F Corica; E Dall'Aglio; R Dalle Grave; P S Morpurgo; F Tomasi; E Vitacolonna
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

2.  Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease.

Authors:  Yoosoo Chang; Seungho Ryu; Eunju Sung; Yumi Jang
Journal:  Clin Chem       Date:  2007-02-01       Impact factor: 8.327

3.  Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases.

Authors:  Min De Zeng; Jian Gao Fan; Lun Gen Lu; You Ming Li; Cheng Wei Chen; Bing Yuan Wang; Yi Min Mao
Journal:  J Dig Dis       Date:  2008-05       Impact factor: 2.325

4.  Higher NAFLD fibrosis score is associated with impaired eGFR.

Authors:  Meng-Hsuan Hsieh; Kuan-Ta Wu; Yi-Yu Chen; Jeng-Fu Yang; Wen-Yi Lin; Ning-Chia Chang; Chia-Yi Lin; Chao-Kuan Huang; Chao-Ling Wang; Hung-Yi Chuang; Shu-Ching Lin; Yu-Kuei Hsu; Yi-Shan Tsai; Wan-Long Chuang; Ming-Lung Yu; Chia-Yen Dai
Journal:  J Formos Med Assoc       Date:  2019-07-25       Impact factor: 3.282

5.  Urinary retinol-binding protein as a risk factor of poor prognosis in acute-on-chronic renal injury.

Authors:  Yanhong Yuan; Chunlin Wang; Xinghua Shao; Qin Wang; Xiajing Che; Minfang Zhang; Yuanyuan Xie; Lei Tian; Zhaohui Ni; Shan Mou
Journal:  J Nephrol       Date:  2016-07-07       Impact factor: 3.902

6.  Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease.

Authors:  X Wang; X Chen; H Zhang; J Pang; J Lin; X Xu; L Yang; J Ma; W Ling; Y Chen
Journal:  Diabetes Metab       Date:  2019-05-09       Impact factor: 6.041

7.  Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities.

Authors:  Kristina Önnerhag; Karl Dreja; Peter M Nilsson; Stefan Lindgren
Journal:  Clin Res Hepatol Gastroenterol       Date:  2019-03-01       Impact factor: 2.947

8.  A high level of urinary retinol-binding protein is associated with cytomegalovirus infection in kidney transplantation.

Authors:  Lúcio R Requião-Moura; Ana C C Matos; Kikumi S Ozaki; Niels O S Câmara; Alvaro Pacheco-Silva
Journal:  Clin Sci (Lond)       Date:  2018-09-18       Impact factor: 6.124

Review 9.  The natural history of non-alcoholic fatty liver disease.

Authors:  Stephen Caldwell; Curtis Argo
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

10.  Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis.

Authors:  Milica Ćulafić; Sandra Vezmar-Kovačević; Violeta Dopsaj; Branislav Oluić; Nemanja Bidžić; Branislava Miljković; Đorđe Ćulafić
Journal:  J Med Biochem       Date:  2020-09-02       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.